984 related articles for article (PubMed ID: 18546146)
21. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
22. In-vitro-induced Th17 cells fail to induce inflammation in vivo and show an impaired migration into inflamed sites.
Janke M; Peine M; Nass A; Morawietz L; Hamann A; Scheffold A
Eur J Immunol; 2010 Apr; 40(4):1089-98. PubMed ID: 20101617
[TBL] [Abstract][Full Text] [Related]
23. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
24. Regulatory properties of copolymer I in Th17 differentiation by altering STAT3 phosphorylation.
Chen C; Liu X; Wan B; Zhang JZ
J Immunol; 2009 Jul; 183(1):246-53. PubMed ID: 19542436
[TBL] [Abstract][Full Text] [Related]
25. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.
Acosta-Rodriguez EV; Napolitani G; Lanzavecchia A; Sallusto F
Nat Immunol; 2007 Sep; 8(9):942-9. PubMed ID: 17676045
[TBL] [Abstract][Full Text] [Related]
26. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
28. Th17 Cells and autoimmune encephalomyelitis (EAE/MS).
Aranami T; Yamamura T
Allergol Int; 2008 Jun; 57(2):115-20. PubMed ID: 18427164
[TBL] [Abstract][Full Text] [Related]
29. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
30. Novel therapeutic targets along the Th17 pathway.
Ouyang W; Filvaroff E; Hu Y; Grogan J
Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720
[TBL] [Abstract][Full Text] [Related]
31. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23.
Morishima N; Mizoguchi I; Takeda K; Mizuguchi J; Yoshimoto T
Biochem Biophys Res Commun; 2009 Aug; 386(1):105-10. PubMed ID: 19501566
[TBL] [Abstract][Full Text] [Related]
33. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.
Brüstle A; Heink S; Huber M; Rosenplänter C; Stadelmann C; Yu P; Arpaia E; Mak TW; Kamradt T; Lohoff M
Nat Immunol; 2007 Sep; 8(9):958-66. PubMed ID: 17676043
[TBL] [Abstract][Full Text] [Related]
34. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity.
Ichiyama K; Hashimoto M; Sekiya T; Nakagawa R; Wakabayashi Y; Sugiyama Y; Komai K; Saba I; Möröy T; Yoshimura A
Int Immunol; 2009 Jul; 21(7):881-9. PubMed ID: 19505891
[TBL] [Abstract][Full Text] [Related]
35. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
[TBL] [Abstract][Full Text] [Related]
36. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
37. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
[TBL] [Abstract][Full Text] [Related]
38. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
39. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
